Saturday, October 31, 2026

Oh Hyun-kyu’s Stellar Performance: 2 Goals and 1 Assist in UEFA Europa League Showdown

Oh Hyun-kyu shined in UEFA Europa League with 2 goals and 1 assist, vowing to fight until the end as long as the coach believes in him.

Hearts2Hearts to Make History as the Only K-Pop Act at Primavera Sound 2027

Hearts2Hearts to perform as the only K-pop group at Primavera Sound 2027.

“Fleeing the Front Line”: PPP Leader Abandons Seoul for D.C. as “Election War” Looms

Han Dong-hyuk's early U.S. trip aims to strengthen U.S.-Korea ties and address economic issues ahead of local elections.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.

SOT106: The Groundbreaking ADC Cancer Drug Fast-Tracked by FDA for Soft Tissue Sarcoma

LigaChem Biosciences' antibody-drug conjugate (ADC) cancer treatment candidate has received Fast Track designation from the FDA.

SK Biopharmaceuticals Secures 795 Million USD License for Groundbreaking Epilepsy Drug Opacalim – What You Need to Know

SK Biopharmaceuticals acquires epilepsy drug candidate from Biohaven for 795 million USD, enhancing its global biotech portfolio.

Revolutionary Wireless Neural Implant: Remote Brain Control from the U.S. to Korea

South Korean researchers developed a wireless device to remotely control a brain implant, delivering drugs and precisely regulating neurons.

Discover TEN’s New Single “OUTWEST”: A Complete Guide to His Upcoming U.S. Tour

Artist Ten expands global influence with his first solo US showcase tour, recently announcing it through an official poster.

Neurophet Partners with Elevate Clinic: How AI is Transforming Brain Injury Diagnosis in the US

Neurophet signs supply contracts with Elevate Clinic for Neurophet Aqua and Neurofit Aqua AD Plus in the U.S. market.

Revolutionary Blood Test for Colorectal Cancer: 90.4% Accuracy Using AI Technology

A domestic study reveals that blood tests can accurately diagnose colorectal cancer with high precision.

Discover Osteo Signal: The AI Solution Revolutionizing Osteoporosis Screening in South Korea

Daewoong Pharmaceutical signs a contract with Promedius for the domestic sales and promotion of the AI osteoporosis screening solution, Osteo Signal.

2026 Breakthrough: How CIK Cell Therapy Aims to Prevent Relapse in High-Risk DLBCL Patients

Clinical research on cell therapy for high-risk diffuse large B-cell lymphoma begins, despite the risk of relapse in complete remission.

JLK Partners with Takeyama: What This Means for AI Stroke Solutions in Japan’s Medical Market

JLK, a medical AI company, partners with Takeyama to expand its distribution network in Japan, enhancing local presence.

HLB Therapeutics’ RGN-259: What to Expect from the Upcoming Topline Results in November 2026?

HLB Therapeutics completed the last patient visit for its RGN-259 treatment in the global Phase 3 trial for neurotrophic keratitis.

In Vivo CAR-T Breakthrough: Abclon and Strike Pharma’s 1 Million EUR Eurostars Project

Abclon's CAR-T therapy project with Strike Pharma has been selected for the Eurostars international tech development program.

How DongKoo Bio & Pharma Maintains Its Dermatology Dominance While Expanding into New Fields

DongKoo Bio & Pharma expands its business into specialized medicine markets, leveraging its prescription competitiveness in dermatology and urology.

Wave 2026: How Wontech is Revolutionizing Aesthetic Medicine in Indonesia and Australia

Wontech hosts global brand events Wave in Indonesia and Australia to expand its overseas medical network and market presence.

Cognitive Training Revolution: Emocog’s Cogthera Surpasses 2000 Prescriptions in Just 12 Weeks

Emocog's digital therapy device Cogthera surpasses 2,000 prescriptions, indicating its successful integration into healthcare for elderly patients.

Top News

- Our Sponsors Ad -

Follow us